Literature DB >> 12868504

Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene.

H Azzedine1, M Ruberg, D Ente, C Gilardeau, S Périé, B Wechsler, A Brice, E LeGuern, O Dubourg.   

Abstract

Charcot-Marie-Tooth (CMT) with autosomal recessive (AR) inheritance is a heterogeneous group of inherited motor and sensory neuropathies. Six genes and five additional loci have been identified that are responsible for either demyelinating or axonal forms of the disease. The gene encoding the ganglioside-induced-differentiation-associated protein 1 (GDAP1) has been associated with both demyelinating and axonal phenotypes. We report a detailed clinical, electrophysiological, and genetic study of two siblings from a Moroccan ARCMT family who are compound heterozygotes for the already described S194X and a new R310Q mutation in the GDAP1 gene. The electrophysiological data are compatible with an axonal form of the disease. The phenotype included hoarse voice and paralysis of the diaphragm. This study shows the variability of the phenotype associated with mutations in GDAP1 gene in terms of associated signs and severity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12868504

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  17 in total

1.  Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach.

Authors:  Magdalena Zimoń; Esra Battaloğlu; Yesim Parman; Sevim Erdem; Jonathan Baets; Els De Vriendt; Derek Atkinson; Leonardo Almeida-Souza; Tine Deconinck; Burcak Ozes; Dirk Goossens; Sebahattin Cirak; Philip Van Damme; Mohammad Shboul; Thomas Voit; Lionel Van Maldergem; Bernard Dan; Mohammed S El-Khateeb; Velina Guergueltcheva; Eduardo Lopez-Laso; Nathalie Goemans; Amira Masri; Stephan Züchner; Vincent Timmerman; Haluk Topaloğlu; Peter De Jonghe; Albena Jordanova
Journal:  Neurogenetics       Date:  2014-09-18       Impact factor: 2.660

Review 2.  Molecular genetics of autosomal-recessive axonal Charcot-Marie-Tooth neuropathies.

Authors:  Rafaëlle Bernard; Annachiara De Sandre-Giovannoli; Valérie Delague; Nicolas Lévy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 3.  Intermediate forms of Charcot-Marie-Tooth neuropathy: a review.

Authors:  Garth Nicholson; Simon Myers
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 4.  Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease.

Authors:  O Dubourg; H Azzedine; C Verny; G Durosier; N Birouk; R Gouider; M Salih; A Bouhouche; A Thiam; D Grid; M Mayer; M Ruberg; M Tazir; A Brice; E LeGuern
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 5.  Axon Transport and Neuropathy: Relevant Perspectives on the Etiopathogenesis of Familial Dysautonomia.

Authors:  Warren G Tourtellotte
Journal:  Am J Pathol       Date:  2015-12-24       Impact factor: 4.307

6.  L239F founder mutation in GDAP1 is associated with a mild Charcot-Marie-Tooth type 4C4 (CMT4C4) phenotype.

Authors:  Dagmara Kabzińska; Halina Strugalska-Cynowska; Anna Kostera-Pruszczyk; Barbara Ryniewicz; Renata Posmyk; Alina Midro; Pavel Seeman; Lucia Báranková; Magdalena Zimoń; Jonathan Baets; Vincent Timmerman; Velina Guergueltcheva; Ivailo Tournev; Stayko Sarafov; Peter De Jonghe; Albena Jordanova; Irena Hausmanowa-Petrusewicz; Andrzej Kochański
Journal:  Neurogenetics       Date:  2010-03-16       Impact factor: 2.660

7.  WES homozygosity mapping in a recessive form of Charcot-Marie-Tooth neuropathy reveals intronic GDAP1 variant leading to a premature stop codon.

Authors:  Marion Masingue; Jimmy Perrot; Robert-Yves Carlier; Guenaelle Piguet-Lacroix; Philippe Latour; Tanya Stojkovic
Journal:  Neurogenetics       Date:  2018-02-02       Impact factor: 2.660

8.  Genotype-phenotype correlation and frequency of distribution in a cohort of Chinese Charcot-Marie-Tooth patients associated with GDAP1 mutations.

Authors:  Pukar Singh Pakhrin; Yongzhi Xie; Zhengmao Hu; Xiaobo Li; Lei Liu; Shunxiang Huang; Binghao Wang; Zihan Yang; Jiejun Zhang; Xin Liu; Kun Xia; Beisha Tang; Ruxu Zhang
Journal:  J Neurol       Date:  2018-01-25       Impact factor: 4.849

9.  Novel GDAP1 mutation in a Turkish family with CMT2K (CMT2K with novel GDAP1 mutation).

Authors:  Nilufer Sahin-Calapoglu; Meliha Tan; Mustafa Soyoz; Mustafa Calapoglu; Nurten Ozcelik
Journal:  Neuromolecular Med       Date:  2009-04-19       Impact factor: 3.843

10.  Charcot-Marie-Tooth disease.

Authors:  Gregory T Carter; Michael D Weiss; Jay J Han; Phillip F Chance; John D England
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.